CMI Joins Pharmaconex 2026 as Strategic Partner to Strengthen Pharmaceutical Market Intelligence Across MENA

Cairo, Egypt | August 2026 — Coherent Market Insights (CMI) has been appointed as a Strategic Partner for https://www.coherentmarketinsights.com/press-release/pharmaconex-2026-to-accelerate-pharmaceutical-growth-4938">Pharmaconex 2026, organized by Informa Egypt LLC, strengthening its engagement with one of the pharmaceutical industry's key platforms in the MENA region.

Scheduled for September 1–3, 2026, at the Egypt International Exhibition Center (EIEC) in Cairo, Pharmaconex 2026 will bring together pharmaceutical manufacturers, technology providers, suppliers, investors, and industry stakeholders from across the region and international markets.

CMI's participation as Strategic Partner reflects the growing importance of market intelligence in an industry experiencing significant structural changes. Pharmaceutical companies across MENA are reassessing manufacturing strategies, supply networks, regulatory pathways, and investment priorities as regional markets continue to evolve.

One of the most notable developments is the increasing focus on API manufacturing and pharmaceutical supply-chain resilience. Companies are exploring greater regional production capabilities while reducing exposure to concentrated global supply sources. At the same time, evolving regulatory requirements are influencing product development, market access, and expansion strategies.